W.C. Ports

Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial

Robert Bissonnette, Kim Papp, Yves Poulin et al. · British Journal of Dermatology · 2016 · 418 citations · Full text

Life Sciences, Dermatology, Pharmacology +15

A randomized phase 2a efficacy and safety trial of the topical <scp>J</scp> anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

W.C. Ports, Sairah Khan, Shu-Ping Lan et al. · British Journal of Dermatology · 2013 · 202 citations · Full text

Medicine, Dermatology, Pharmacology +13

Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study

Fernando Valenzuela, Neil J. Korman, Robert Bissonnette et al. · British Journal of Dermatology · 2018 · 55 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Examining the association between pruritus and quality of life in patients with atopic dermatitis treated with crisaborole

Sonja Ständer, Gil Yosipovitch, Andrew G. Bushmakin et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 17 citations

Medicine, Dermatology, Pharmacotherapy +15

Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area

Jonathan I. Silverberg, Anna M. Tallman, W.C. Ports et al. · Acta Dermato Venereologica · 2020 · 15 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14